Cargando…

S56. PHOENIX GROUP, A PROJECT TO PREVENT RELAPSES IN SCHIZOPHRENIA

BACKGROUND: Schizophrenia is a syndrome of variable and highly disruptive psychopathology that infers emotion, perception, and several aspects of behavior. Relapses caused by noncompliance are common and may lead to hospitalizations. In many ways they increase social disability and health care costs...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiramberro, Marcelo, Kieseppä, Tuula, Wegelius, Asko, Töhönen, Tuomo, Ilvonen, Jenna, Väisänen, Heli, Sarkkinen, Katja, Tikkala, Jenni, Leiponen, Marita, Ruppa, Markku, Hyytiäinen, Matias, Hynninen-Sundelin, Ira, Anttonen, Esa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888543/
http://dx.doi.org/10.1093/schbul/sby018.843
_version_ 1783312546913058816
author Chiramberro, Marcelo
Kieseppä, Tuula
Wegelius, Asko
Töhönen, Tuomo
Ilvonen, Jenna
Väisänen, Heli
Sarkkinen, Katja
Tikkala, Jenni
Leiponen, Marita
Ruppa, Markku
Hyytiäinen, Matias
Hynninen-Sundelin, Ira
Anttonen, Esa
author_facet Chiramberro, Marcelo
Kieseppä, Tuula
Wegelius, Asko
Töhönen, Tuomo
Ilvonen, Jenna
Väisänen, Heli
Sarkkinen, Katja
Tikkala, Jenni
Leiponen, Marita
Ruppa, Markku
Hyytiäinen, Matias
Hynninen-Sundelin, Ira
Anttonen, Esa
author_sort Chiramberro, Marcelo
collection PubMed
description BACKGROUND: Schizophrenia is a syndrome of variable and highly disruptive psychopathology that infers emotion, perception, and several aspects of behavior. Relapses caused by noncompliance are common and may lead to hospitalizations. In many ways they increase social disability and health care costs. The project’s philosophy was based on the motivation of the patients to continue their treatment, improve their quality of life, and reduce disease relapses, which in turn reduces public health care costs. METHODS: We enrolled 10 schizophrenia and schizoaffective patients with a poor treatment adhesion in a pilot group. All the patients were at the acute psychosis ward. The patient’s average hospitalization days were 180 days/year, and they were highly noncompliant with the open ward treatment accompanied with assertive community treatment model. Seven patients had depot injections and three patients had oral antipsychotic medication. During the hospital treatment the patients started in a group, which continued after the discharge. Weekly group meetings with different activities were organized at the hospital by the ward personnel. The doctor, nurses, a psychologist and an occupational therapist participated the group with different combinations and in a nonhierarchical manner. Psychoeducation was used to increase the knowledge and coping with the disorder. Functional group activities like cooking, arts and visits to different places were organized. The clinical parameters including the work status, relapse rates and hospitalization days were evaluated at every 6-months during 18 months. For the clinical measurements we used the Brief Psychiatric Rating Scale (BPRS) and 15D Health Related Quality of Life instrument. RESULTS: At 18 months follow-up, eight of 10 group members had not needed hospitalization at all, one needed hospitalization of 15 days and another 20 days. Both of them were in voluntary treatment. During the pilot stage, two patients got jobs. At five year follow-up, five of 10 initial patients were full-time employed persons. None have needed hospitalization after 18 months. DISCUSSION: The intensive group focused on noncompliant patients, organized by the hospital ward, where these patients had been recurrently treated, improved substantially the patients’ commitment to the treatment and decreased rehospitalizations. The non-hierarchical group operating in the interface of the hospital and open ward was able to cause a significant reduction of general health costs and an improvement in the quality of life of these patients. They were reintegrated into society, and the stigma and marginalization associated with psychoses decreased while the self-esteem improved. The patients were able to create friendships with others in the same situations. They helped one another, and thus also improved their own self-help capacity. These elements prevent social isolation, treatment nonadherence and functional deterioration, which also would be a risk for increased violence and suicide. The group meetings began during the hospital treatment, and the patients intensively continued in the familial group after the discharge. However, the goal for these patients is gradually to leave the group and attend other open-ward, occupational and social activities. CONCLUSIONS: Through psycho-educational interventions combined with pharmacological and psychological treatments, Phoenix group, a patient orientated, peer supporting and hospital wall-breaking method obtains results clearly observable that we can warmly recommend.
format Online
Article
Text
id pubmed-5888543
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58885432018-04-11 S56. PHOENIX GROUP, A PROJECT TO PREVENT RELAPSES IN SCHIZOPHRENIA Chiramberro, Marcelo Kieseppä, Tuula Wegelius, Asko Töhönen, Tuomo Ilvonen, Jenna Väisänen, Heli Sarkkinen, Katja Tikkala, Jenni Leiponen, Marita Ruppa, Markku Hyytiäinen, Matias Hynninen-Sundelin, Ira Anttonen, Esa Schizophr Bull Abstracts BACKGROUND: Schizophrenia is a syndrome of variable and highly disruptive psychopathology that infers emotion, perception, and several aspects of behavior. Relapses caused by noncompliance are common and may lead to hospitalizations. In many ways they increase social disability and health care costs. The project’s philosophy was based on the motivation of the patients to continue their treatment, improve their quality of life, and reduce disease relapses, which in turn reduces public health care costs. METHODS: We enrolled 10 schizophrenia and schizoaffective patients with a poor treatment adhesion in a pilot group. All the patients were at the acute psychosis ward. The patient’s average hospitalization days were 180 days/year, and they were highly noncompliant with the open ward treatment accompanied with assertive community treatment model. Seven patients had depot injections and three patients had oral antipsychotic medication. During the hospital treatment the patients started in a group, which continued after the discharge. Weekly group meetings with different activities were organized at the hospital by the ward personnel. The doctor, nurses, a psychologist and an occupational therapist participated the group with different combinations and in a nonhierarchical manner. Psychoeducation was used to increase the knowledge and coping with the disorder. Functional group activities like cooking, arts and visits to different places were organized. The clinical parameters including the work status, relapse rates and hospitalization days were evaluated at every 6-months during 18 months. For the clinical measurements we used the Brief Psychiatric Rating Scale (BPRS) and 15D Health Related Quality of Life instrument. RESULTS: At 18 months follow-up, eight of 10 group members had not needed hospitalization at all, one needed hospitalization of 15 days and another 20 days. Both of them were in voluntary treatment. During the pilot stage, two patients got jobs. At five year follow-up, five of 10 initial patients were full-time employed persons. None have needed hospitalization after 18 months. DISCUSSION: The intensive group focused on noncompliant patients, organized by the hospital ward, where these patients had been recurrently treated, improved substantially the patients’ commitment to the treatment and decreased rehospitalizations. The non-hierarchical group operating in the interface of the hospital and open ward was able to cause a significant reduction of general health costs and an improvement in the quality of life of these patients. They were reintegrated into society, and the stigma and marginalization associated with psychoses decreased while the self-esteem improved. The patients were able to create friendships with others in the same situations. They helped one another, and thus also improved their own self-help capacity. These elements prevent social isolation, treatment nonadherence and functional deterioration, which also would be a risk for increased violence and suicide. The group meetings began during the hospital treatment, and the patients intensively continued in the familial group after the discharge. However, the goal for these patients is gradually to leave the group and attend other open-ward, occupational and social activities. CONCLUSIONS: Through psycho-educational interventions combined with pharmacological and psychological treatments, Phoenix group, a patient orientated, peer supporting and hospital wall-breaking method obtains results clearly observable that we can warmly recommend. Oxford University Press 2018-04 2018-04-01 /pmc/articles/PMC5888543/ http://dx.doi.org/10.1093/schbul/sby018.843 Text en © Maryland Psychiatric Research Center 2018. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Chiramberro, Marcelo
Kieseppä, Tuula
Wegelius, Asko
Töhönen, Tuomo
Ilvonen, Jenna
Väisänen, Heli
Sarkkinen, Katja
Tikkala, Jenni
Leiponen, Marita
Ruppa, Markku
Hyytiäinen, Matias
Hynninen-Sundelin, Ira
Anttonen, Esa
S56. PHOENIX GROUP, A PROJECT TO PREVENT RELAPSES IN SCHIZOPHRENIA
title S56. PHOENIX GROUP, A PROJECT TO PREVENT RELAPSES IN SCHIZOPHRENIA
title_full S56. PHOENIX GROUP, A PROJECT TO PREVENT RELAPSES IN SCHIZOPHRENIA
title_fullStr S56. PHOENIX GROUP, A PROJECT TO PREVENT RELAPSES IN SCHIZOPHRENIA
title_full_unstemmed S56. PHOENIX GROUP, A PROJECT TO PREVENT RELAPSES IN SCHIZOPHRENIA
title_short S56. PHOENIX GROUP, A PROJECT TO PREVENT RELAPSES IN SCHIZOPHRENIA
title_sort s56. phoenix group, a project to prevent relapses in schizophrenia
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888543/
http://dx.doi.org/10.1093/schbul/sby018.843
work_keys_str_mv AT chiramberromarcelo s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT kieseppatuula s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT wegeliusasko s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT tohonentuomo s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT ilvonenjenna s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT vaisanenheli s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT sarkkinenkatja s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT tikkalajenni s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT leiponenmarita s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT ruppamarkku s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT hyytiainenmatias s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT hynninensundelinira s56phoenixgroupaprojecttopreventrelapsesinschizophrenia
AT anttonenesa s56phoenixgroupaprojecttopreventrelapsesinschizophrenia